CD8A and neoplasm: Innate αβ T cells (iαβTs) demonstrate tumor-protective properties by reprogramming immunogenic macrophages in a CCR5-dependent manner and inhibiting CD8+ T cell activation through PD-L1/PD-1 interactions90.